166 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34404919 | Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection. | 2022 Jan | 2 |
2 | 35007301 | SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. | 2022 | 2 |
3 | 35286219 | Mitophagy induction and aryl hydrocarbon receptor-mediated redox signaling contribute to the suppression of breast cancer cell growth by raloxifene via regulation of inflammasomes activation. | 2022 Mar 14 | 5 |
4 | 35614039 | Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants. | 2022 May 25 | 2 |
5 | 32940862 | Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. | 2021 Feb | 3 |
6 | 33882282 | Endocrine prevention of breast cancer. | 2021 Jun 15 | 1 |
7 | 34319769 | Breast Cancer Prevention: Time for Change. | 2021 Dec | 2 |
8 | 34398352 | Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team. | 2021 Nov | 1 |
9 | 34509864 | Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activities. | 2021 Oct 1 | 1 |
10 | 34572301 | Raloxifene Ameliorates Glucosamine-Induced Insulin Resistance in Ovariectomized Rats. | 2021 Aug 30 | 2 |
11 | 34630393 | Sex Hormones and Aging Modulate Interferon Lambda 1 Production and Signaling by Human Uterine Epithelial Cells and Fibroblasts. | 2021 | 2 |
12 | 32068570 | Do we need sex-oriented clinical practice guidelines for the treatment of schizophrenia? | 2020 May | 1 |
13 | 32482672 | Identification of Estrogen Receptor Modulators as Inhibitors of Flavivirus Infection. | 2020 Jul 22 | 1 |
14 | 32656689 | Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy. | 2020 Dec | 2 |
15 | 32871847 | Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality. | 2020 Sep-Oct | 1 |
16 | 33033707 | An Overview of Cancer Prevention: Chemoprevention and Immunoprevention. | 2020 Sep 30 | 1 |
17 | 33066585 | Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start. | 2020 Oct 14 | 2 |
18 | 31073029 | The selective estrogen receptor modulator raloxifene mitigates the effect of all-trans-retinal toxicity in photoreceptor degeneration. | 2019 Jun 14 | 1 |
19 | 31494144 | Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians. | 2019 Dec | 1 |
20 | 28859903 | Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ERα and PPAR-γ. | 2018 Feb 5 | 1 |
21 | 28924735 | The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer. | 2018 Jan | 1 |
22 | 29482944 | Synthesis and biological evaluation of 4,6-diaryl-2-pyrimidinamine derivatives as anti-breast cancer agents. | 2018 Apr 1 | 1 |
23 | 30241506 | The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women. | 2018 Sep 21 | 1 |
24 | 28396978 | A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy. | 2017 Jun | 1 |
25 | 26133657 | Effect of selective estrogen receptor modulators on metabolic homeostasis. | 2016 May | 1 |
26 | 26648459 | A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. | 2016 Jan | 3 |
27 | 27185013 | Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator. | 2016 Jul 1 | 1 |
28 | 27203377 | Controlling Sulfuryl-Transfer Biology. | 2016 May 19 | 3 |
29 | 27546373 | Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial. | 2016 Oct | 1 |
30 | 27576059 | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 Nov | 1 |
31 | 27842943 | Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype. | 2016 Dec | 5 |
32 | 28003814 | The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation. | 2016 | 1 |
33 | 25410727 | In vitro evaluation of a tetrahydroisoquinoline derivative as a steroid sulfatase inhibitor and a selective estrogen receptor modulator. | 2015 Feb | 1 |
34 | 25537862 | Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of AMP-activated protein kinase. | 2015 | 3 |
35 | 25795461 | Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cells. | 2015 Jun | 1 |
36 | 26289836 | Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. | 2015 Sep | 3 |
37 | 26529585 | Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells. | 2015 | 3 |
38 | 23727128 | Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. | 2014 Jul | 1 |
39 | 24481452 | The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells. | 2014 Jan 30 | 5 |
40 | 24498137 | Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα. | 2014 | 1 |
41 | 24785473 | Oestrogen induced downregulation of TFPI expression is mediated by ERα. | 2014 Jul | 1 |
42 | 24829621 | Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer. | 2014 | 2 |
43 | 24930824 | Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations. | 2014 Nov | 1 |
44 | 25084324 | From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). | 2014 Nov | 2 |
45 | 25378950 | Preventative therapies for healthy women at high risk of breast cancer. | 2014 | 1 |
46 | 23613312 | Design, synthesis, and biological evaluation of cyclopropyl analogues of stilbene with raloxifene side chain as subtype-selective ligands for estrogen receptor. | 2013 Sep | 1 |
47 | 23634843 | Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. | 2013 May 1 | 3 |
48 | 23915737 | Breast cancer prevention by antihormones and other drugs: where do we stand? | 2013 Aug | 2 |
49 | 24015958 | The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed. | 2013 Sep | 2 |
50 | 24069582 | Targeted therapy for breast cancer prevention. | 2013 Sep 23 | 1 |